Validation of the Methotrexate-First Strategy in Patients With Early, Poor-Prognosis Rheumatoid Arthritis: Results From a Two-Year Randomized, Double-Blind Trial-Reference-Cited by-同舟云学术

Validation of the Methotrexate-First Strategy in Patients With Early, Poor-Prognosis Rheumatoid Arthritis: Results From a Two-Year Randomized, Double-Blind Trial

Published:2013-07-26 Issue:8 Volume:65 Page:1985-1994
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

O'Dell James R.¹,Curtis Jeffrey R.²,Mikuls Ted R.¹,Cofield Stacey S.²,Bridges S. Louis²,Ranganath Veena K.³,Moreland Larry W.⁴,

Affiliation:

1. University of Nebraska and Omaha VA Medical Center; Omaha

2. University of Alabama at Birmingham

3. University of California at Los Angeles

4. University of Pittsburgh; Pittsburgh Pennsylvania

Funder

NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases planning)

Arthritis Foundation

Agency for Healthcare Research and Quality

Rheumatology Research Foundation

Margaret J. Miller Endowed Professor of Arthritis Research Chair at the University of Pittsburgh

Amgen

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.38012/fullpdf

Reference36 articles.

1. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis;Singh;Arthritis Care Res (Hoboken),2012

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs;Smolen;Ann Rheum Dis,2010

3. Rheumatoid arthritis;McInnes;Ann Rheum Dis,2010

4. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications;O'Dell;N Engl J Med,1996

5. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial;Mottonen;Lancet,1999

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors of methotrexate monotherapy success in patients with rheumatoid arthritis in a national referral center: a cohort study;BMC Rheumatology;2024-09-12

2. Predictive Factors of Methotrexate Monotherapy Success in Patients with Rheumatoid Arthritis in a National Referral Center: A Cohort Study;2024-07-22

3. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide;Reumatología Clínica;2024-07

4. The universal presence of poor prognostic factors based on EULAR recommendations: A real-world study in 1164 Chinese RA patients;Joint Bone Spine;2023-12

5. Epigenetic and transcriptional regulation of CCL17 production by glucocorticoids in arthritis;iScience;2023-10